GSK Expands Respiratory Pipeline With Aiolos Bio Buy -- 2nd

By Christian Moess Laursen


GSK is buying biopharmaceutical company Aiolos Bio for up to $1.4 billion in a deal that expands its respiratory pipeline and follows a string of pharmaceutical...

Related Keywords

San Francisco , California , United States , United Kingdom , Bristol , City Of , British , Tony Wood , Karuna Therapeuticsno , Christian Moess Laursen , Aiolos Bio , Bellus Health Inc , Novartis , London Based Aiolos Bio , Scientific Officer Tony Wood , Wall Street Journal , Bellus Health , Dow Jones , Markets ,